Quince Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Quince Therapeutics, Inc. (QNCX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $3.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$362.00K, a 201.69% decline year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $3.64M.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$2.74M.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $374.00K.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.96M, a 272.82% decline from fiscal 2024.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.71M.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$4.25M.
- Quince Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.58M, a 411.22% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.28M 10-Q · filed 2026-08-14 | $534.00K derived: sum of 3 quarters · filed 2026-08-14 | $908.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $3.64M 10-Q · filed 2026-05-11 | $896.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.27M derived: sum of 3 quarters · filed 2026-05-11 | $1.63M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$2.37M derived: sum of 2 quarters · filed 2026-04-10 | -$2.01M derived: sum of 3 quarters · filed 2026-08-14 | -$2.96M 10-K · filed 2026-04-10 |
| 2025-09-30 | $374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $730.00K derived: sum of 2 quarters · filed 2026-08-14 | -$214.00K 10-Q · filed 2025-11-12 | -$528.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$588.00K 10-Q · filed 2026-08-14 | -$902.00K derived: sum of 3 quarters · filed 2026-08-14 | -$919.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$944.00K 10-Q · filed 2026-05-11 | -$1.26M derived: sum of 2 quarters · filed 2026-05-11 | -$1.27M derived: sum of 3 quarters · filed 2026-05-11 | $327.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$331.00K derived: sum of 2 quarters · filed 2026-04-10 | $1.27M derived: sum of 3 quarters · filed 2026-04-10 | $1.71M 10-K · filed 2026-04-10 |
| 2024-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.58M derived: sum of 2 quarters · filed 2025-11-12 | $2.02M 10-Q · filed 2025-11-12 | $51.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.04M 10-Q · filed 2025-08-11 | $68.00K derived: sum of 3 quarters · filed 2025-08-11 | $511.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $440.00K 10-Q · filed 2025-05-13 | -$1.53M derived: sum of 2 quarters · filed 2025-05-13 | -$1.09M derived: sum of 3 quarters · filed 2025-05-13 | -$2.39M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$1.53M derived: sum of 2 quarters · filed 2025-03-24 | -$2.83M derived: sum of 3 quarters · filed 2025-03-24 | -$4.25M 10-K · filed 2025-03-24 |
| 2023-09-30 | $443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$859.00K derived: sum of 2 quarters · filed 2024-11-13 | -$2.27M 10-Q · filed 2024-11-13 | -$2.46M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.71M 10-Q · filed 2024-08-13 | -$2.90M derived: sum of 3 quarters · filed 2024-08-13 | -$3.54M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$1.41M 10-Q · filed 2024-05-13 | -$1.60M derived: sum of 2 quarters · filed 2024-05-13 | -$2.24M derived: sum of 3 quarters · filed 2024-05-13 | -$3.95M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$830.00K derived: sum of 2 quarters · filed 2024-04-01 | -$2.54M derived: sum of 3 quarters · filed 2024-04-01 | -$2.58M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$646.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.35M derived: sum of 2 quarters · filed 2023-11-14 | -$2.40M 10-Q · filed 2023-11-14 | -$2.54M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.75M 10-Q · filed 2023-08-03 | -$1.89M derived: sum of 3 quarters · filed 2023-08-03 | -$2.77M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$42.00K 10-Q · filed 2023-05-15 | -$186.00K derived: sum of 2 quarters · filed 2023-05-15 | -$1.06M derived: sum of 3 quarters · filed 2023-05-15 | $1.98M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$1.02M derived: sum of 2 quarters · filed 2023-03-15 | $2.02M derived: sum of 3 quarters · filed 2023-03-15 | $829.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$878.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.17M derived: sum of 2 quarters · filed 2022-11-09 | $973.00K 10-Q · filed 2022-11-09 | -$167.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.85M 10-Q · filed 2022-08-09 | $711.00K derived: sum of 3 quarters · filed 2022-08-09 | -$1.21M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$1.19M 10-Q · filed 2022-05-10 | -$2.33M derived: sum of 2 quarters · filed 2022-05-10 | -$4.26M derived: sum of 3 quarters · filed 2022-05-10 | -$3.33M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$3.06M derived: sum of 2 quarters · filed 2022-03-01 | -$2.13M derived: sum of 3 quarters · filed 2022-03-01 | -$2.18M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$995.00K derived: sum of 2 quarters · filed 2021-10-29 | -$1.04M 10-Q · filed 2021-10-29 | $999.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $880.00K 10-Q · filed 2021-08-06 | $2.92M derived: sum of 3 quarters · filed 2022-03-01 | $1.69M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$49.00K 10-Q · filed 2021-05-06 | $1.99M derived: sum of 2 quarters · filed 2022-03-01 | $760.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.65M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $809.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.70M derived: sum of 3 quarters · filed 2022-03-01 | $5.32M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$347.00K derived: sum of 2 quarters · filed 2020-11-12 | $3.28M 10-Q · filed 2020-11-12 | $3.99M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $887.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $4.51M 10-Q · filed 2020-08-14 | $5.22M derived: sum of 3 quarters · filed 2021-03-01 | $4.94M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $3.63M 10-Q · filed 2020-05-12 | $4.34M derived: sum of 2 quarters · filed 2021-03-01 | $4.05M derived: sum of 3 quarters · filed 2021-03-01 | $4.24M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $425.00K derived: sum of 2 quarters · filed 2021-03-01 | $610.00K derived: sum of 3 quarters · filed 2021-03-01 | $690.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | -$285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$100.00K derived: sum of 2 quarters · filed 2019-11-12 | -$20.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $265.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $80.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |